Reading Genotype and Co-medication Effects with Parameter Uncertainty

Why the Point Estimate Is Not the Whole Result

A genotype or concomitant medication may be associated with a substantial estimated change in clearance, yet the estimate can be imprecise. Conversely, a modest estimated change may be measured with comparatively little uncertainty. Reading the number alone hides this distinction. Interpretation therefore requires both the estimated effect and information about its uncertainty.

This tutorial considers covariate effects expressed as coefficients in a population pharmacokinetic model. For clarity, the examples use apparent clearance, \(CL/F\), and a log-linear parameterization. The same reasoning applies to other positive pharmacokinetic parameters when their covariate effects are modeled on the log scale. Genotype coding and medication-covariate construction determine what a coefficient represents; here, each is treated as already defined for the contrast of interest.

For example, if \(\beta_G\) is the coefficient for carrying a specified genotype, then \(\exp(\beta_G)=0.70\) means that the model estimates the typical parameter for carriers to be 70% of the reference value, conditional on the other modeled covariates. It corresponds to an estimated 30% lower parameter value. This is a model-based association, not by itself evidence that genotype caused the difference.

Confidence Intervals and Relative Standard Errors

A standard error describes the estimated sampling uncertainty of a coefficient under the fitted model and its estimation assumptions. In a large-sample Wald approximation, the estimate \(\hat{\beta}\) is treated as approximately normally distributed around the underlying coefficient, with estimated standard error \(SE(\hat{\beta})\). An approximate 95% confidence interval is therefore the estimate plus or minus 1.96 standard errors.

This interval has a repeated-sampling interpretation: under the model and approximation, intervals constructed this way would contain the underlying coefficient in about 95% of repetitions. It is not a statement that the fixed coefficient has a 95% probability of lying in this particular interval. The interval is conditional on the model and data analysis; it does not automatically account for model misspecification, biased covariate records, or unmeasured confounding.

Because \(\exp(\beta)\) is a parameter ratio, exponentiating both endpoints gives an interval for that ratio. The exponential function is increasing, so the endpoint order is preserved. The resulting ratio interval is generally asymmetric around \(\exp(\hat{\beta})\), even though the coefficient-scale Wald interval is symmetric.

The relative standard error (RSE) expresses the standard error as a percentage of the magnitude of the estimate:

RSE is a scale-dependent summary, not a confidence interval or a direct measure of biological importance. It can help flag an estimate whose uncertainty is large relative to its magnitude. It becomes unstable when the estimate is near zero, and a large RSE does not, on its own, establish that an estimate is unusable. Always inspect the estimate, its standard error, and its interval together.

Worked Interpretations

Using Correlations Between Parameter Estimates

A model estimates parameters together. Consequently, two coefficient estimates may be correlated: changes in one estimate may tend to accompany changes in the other while the model fits the data similarly. This is a feature of estimation uncertainty, not necessarily a biological correlation between genotype and medication effects. The covariance matrix records this uncertainty; a correlation is the covariance scaled by the two standard errors.

When a contrast combines estimated coefficients, its uncertainty depends on their covariance. For two estimates \(\hat{\beta}_1\) and \(\hat{\beta}_2\), the variance of their sum includes twice their covariance. Omitting that term implicitly assumes zero correlation.

If their estimated correlation is \(\rho\), then \(\mathrm{Cov}(\hat{\beta}_1,\hat{\beta}_2)=\rho\,SE(\hat{\beta}_1)SE(\hat{\beta}_2)\). Positive correlation increases the variance of a sum; negative correlation decreases it. The direction reverses for a difference, because the covariance term then has a minus sign.

Assumptions, Comparisons, and Failure Modes

The Wald intervals above require that the estimates are approximately normal on the coefficient scale and that their standard errors adequately represent sampling uncertainty. This approximation is most credible when the model is identifiable, estimation has converged to a meaningful solution, and the likelihood is sufficiently informative around the estimates. Sparse genotype or medication groups, weak covariate overlap, and highly correlated model terms can undermine that approximation. An interval computed from an unreliable standard error does not become reliable just because its formula is simple.

The covariance matrix should be inspected when interpreting combined contrasts. Very high parameter correlations can signal that the data provide limited ability to distinguish particular effects. A near-zero estimate also makes its RSE especially hard to interpret; report the coefficient-scale interval and, where meaningful, the ratio-scale interval rather than relying on a percentage alone. These are checks on uncertainty summaries, not substitutes for evaluating the data and fitted model.

A Wald interval is convenient and makes the role of standard errors and correlations explicit. Alternatives include profile-likelihood intervals, which use the shape of the likelihood rather than a symmetric normal approximation, and bootstrap intervals, which use resampling to assess the sampling distribution under the chosen resampling scheme. These approaches can behave differently when estimates are near parameter boundaries or the likelihood is asymmetric. None automatically corrects a misspecified model or biased covariate information. A Bayesian credible interval has a different interpretation and depends on a specified prior as well as the data and model.

The main practical failure is to treat a point estimate as a precise subgroup difference. A ratio of 0.70 and a ratio of 0.70 with a very wide interval are not equally informative results. Likewise, a small RSE cannot certify that the model’s covariate coding is appropriate. Interpret estimates in the context of the reference group, the parameter scale, the uncertainty, and the assumptions that produced them.

• Wrong: “The RSE is 40%, so the effect is a 40% decrease.” Correction: RSE is the standard error divided by the absolute coefficient estimate; it is not the estimated percent change in the pharmacokinetic parameter.
• Wrong: “The genotype coefficient is negative, so clearance is lower by that many units.” Correction: For a log-linear model, exponentiate the coefficient to obtain a multiplicative ratio; it is not an additive change in clearance units.
• Wrong: “The two coefficient estimates are correlated, so genotype and medication are biologically correlated.” Correction: Their estimated correlation describes joint estimation uncertainty; it does not establish a biological relationship.
• Wrong: “The combined interval can be calculated by adding the two standard errors.” Correction: Calculate the variance using both standard errors and their covariance, then take the square root.